| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncolytic Virotherapy | 61 | 2024 | 498 | 11.160 |
Why?
|
| Glioblastoma | 118 | 2024 | 3481 | 10.530 |
Why?
|
| Brain Neoplasms | 189 | 2024 | 8863 | 9.860 |
Why?
|
| Oncolytic Viruses | 46 | 2024 | 327 | 9.690 |
Why?
|
| Glioma | 91 | 2023 | 3401 | 6.810 |
Why?
|
| Herpesvirus 1, Human | 59 | 2023 | 743 | 5.960 |
Why?
|
| Genetic Vectors | 84 | 2022 | 3420 | 4.090 |
Why?
|
| Simplexvirus | 40 | 2022 | 802 | 3.970 |
Why?
|
| Neurosurgical Procedures | 21 | 2022 | 2002 | 2.970 |
Why?
|
| Meningioma | 19 | 2022 | 1209 | 2.750 |
Why?
|
| Virus Replication | 46 | 2018 | 2534 | 2.130 |
Why?
|
| Meningeal Neoplasms | 18 | 2022 | 1241 | 2.070 |
Why?
|
| Immunotherapy | 27 | 2024 | 4445 | 1.980 |
Why?
|
| Adenoviridae | 18 | 2016 | 1099 | 1.870 |
Why?
|
| Central Nervous System Neoplasms | 12 | 2014 | 895 | 1.790 |
Why?
|
| Cyclophosphamide | 22 | 2009 | 2242 | 1.660 |
Why?
|
| Cancer Vaccines | 9 | 2018 | 1023 | 1.600 |
Why?
|
| Gene Transfer Techniques | 26 | 2019 | 1224 | 1.270 |
Why?
|
| Neurosurgery | 9 | 2022 | 643 | 1.260 |
Why?
|
| Neoplasms | 32 | 2023 | 21683 | 1.230 |
Why?
|
| Viruses | 9 | 2016 | 374 | 1.220 |
Why?
|
| Tumor Microenvironment | 22 | 2024 | 3586 | 1.190 |
Why?
|
| Radiosurgery | 7 | 2014 | 1329 | 1.180 |
Why?
|
| MicroRNAs | 23 | 2020 | 3752 | 1.170 |
Why?
|
| Neoplastic Stem Cells | 18 | 2020 | 1376 | 1.160 |
Why?
|
| Transgenes | 17 | 2009 | 1009 | 1.130 |
Why?
|
| Thymidine Kinase | 15 | 2016 | 290 | 1.060 |
Why?
|
| Antineoplastic Agents, Alkylating | 13 | 2020 | 627 | 1.020 |
Why?
|
| Herpes Simplex | 11 | 2021 | 470 | 1.020 |
Why?
|
| Neoplasm Recurrence, Local | 19 | 2022 | 9239 | 0.990 |
Why?
|
| Mice, Nude | 48 | 2020 | 3689 | 0.980 |
Why?
|
| Humans | 353 | 2024 | 744343 | 0.980 |
Why?
|
| Craniotomy | 8 | 2015 | 729 | 0.890 |
Why?
|
| Cell Line, Tumor | 57 | 2022 | 16689 | 0.880 |
Why?
|
| Cytochrome P-450 CYP2B1 | 7 | 2005 | 21 | 0.880 |
Why?
|
| Exosomes | 6 | 2020 | 417 | 0.880 |
Why?
|
| Animals | 197 | 2023 | 168757 | 0.870 |
Why?
|
| Gliosarcoma | 17 | 2001 | 114 | 0.860 |
Why?
|
| Monitoring, Intraoperative | 4 | 2014 | 957 | 0.860 |
Why?
|
| Killer Cells, Natural | 8 | 2022 | 2133 | 0.840 |
Why?
|
| Gene Expression Regulation, Neoplastic | 24 | 2023 | 8428 | 0.830 |
Why?
|
| Tumor Cells, Cultured | 47 | 2020 | 6314 | 0.830 |
Why?
|
| Prodrugs | 12 | 2020 | 268 | 0.800 |
Why?
|
| Astrocytoma | 7 | 2015 | 790 | 0.780 |
Why?
|
| Interferon-gamma | 9 | 2023 | 3206 | 0.770 |
Why?
|
| Clinical Trials as Topic | 26 | 2024 | 7913 | 0.760 |
Why?
|
| Mice | 119 | 2023 | 81183 | 0.760 |
Why?
|
| Interleukin-12 | 2 | 2022 | 579 | 0.750 |
Why?
|
| Histone Deacetylases | 3 | 2015 | 728 | 0.750 |
Why?
|
| Aminolevulinic Acid | 2 | 2011 | 142 | 0.740 |
Why?
|
| Neoplasms, Experimental | 7 | 2019 | 1276 | 0.730 |
Why?
|
| Antineoplastic Agents | 26 | 2018 | 13695 | 0.730 |
Why?
|
| Peripheral Nervous System Neoplasms | 4 | 2009 | 122 | 0.730 |
Why?
|
| Supratentorial Neoplasms | 2 | 2012 | 160 | 0.720 |
Why?
|
| Chromosomes, Artificial, Bacterial | 8 | 2014 | 126 | 0.710 |
Why?
|
| Neovascularization, Pathologic | 12 | 2019 | 2635 | 0.710 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2015 | 789 | 0.700 |
Why?
|
| Xenograft Model Antitumor Assays | 23 | 2022 | 3557 | 0.700 |
Why?
|
| Blood-Brain Barrier | 10 | 2022 | 1017 | 0.700 |
Why?
|
| Cytomegalovirus Infections | 5 | 2021 | 820 | 0.680 |
Why?
|
| Ganciclovir | 12 | 2004 | 258 | 0.680 |
Why?
|
| Gene Expression | 24 | 2018 | 7799 | 0.680 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2019 | 31 | 0.680 |
Why?
|
| Spheroids, Cellular | 8 | 2017 | 351 | 0.640 |
Why?
|
| Skull Neoplasms | 3 | 2015 | 173 | 0.640 |
Why?
|
| Poliovirus | 1 | 2018 | 109 | 0.640 |
Why?
|
| Tumor Escape | 2 | 2021 | 349 | 0.630 |
Why?
|
| Combined Modality Therapy | 24 | 2018 | 8642 | 0.630 |
Why?
|
| Protein Phosphatase 1 | 1 | 2018 | 137 | 0.610 |
Why?
|
| Molecular Targeted Therapy | 4 | 2019 | 2727 | 0.590 |
Why?
|
| Photosensitizing Agents | 2 | 2011 | 602 | 0.580 |
Why?
|
| Wakefulness | 3 | 2015 | 1245 | 0.570 |
Why?
|
| Antigens, Neoplasm | 7 | 2021 | 1988 | 0.560 |
Why?
|
| Central Nervous System Cysts | 1 | 2016 | 58 | 0.560 |
Why?
|
| Neoplasm, Residual | 2 | 2013 | 973 | 0.560 |
Why?
|
| Comovirus | 1 | 2015 | 5 | 0.560 |
Why?
|
| Valproic Acid | 4 | 2015 | 445 | 0.560 |
Why?
|
| Dermoid Cyst | 1 | 2016 | 93 | 0.540 |
Why?
|
| Viral Proteins | 10 | 2017 | 1900 | 0.530 |
Why?
|
| Defective Viruses | 3 | 2013 | 112 | 0.530 |
Why?
|
| Postoperative Complications | 8 | 2018 | 15295 | 0.520 |
Why?
|
| Magnetic Resonance Imaging | 37 | 2021 | 35421 | 0.520 |
Why?
|
| Lymphoma, B-Cell | 3 | 2013 | 931 | 0.520 |
Why?
|
| Helper Viruses | 4 | 2003 | 58 | 0.520 |
Why?
|
| Brachial Plexus Neuropathies | 2 | 2009 | 122 | 0.500 |
Why?
|
| Immune Evasion | 1 | 2018 | 360 | 0.490 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2016 | 194 | 0.480 |
Why?
|
| Dura Mater | 3 | 2012 | 291 | 0.470 |
Why?
|
| Craniopharyngioma | 1 | 2016 | 281 | 0.470 |
Why?
|
| Peptides | 5 | 2020 | 4409 | 0.470 |
Why?
|
| STAT3 Transcription Factor | 4 | 2020 | 873 | 0.470 |
Why?
|
| Transfection | 15 | 2010 | 5892 | 0.460 |
Why?
|
| Neoplasm Invasiveness | 14 | 2017 | 3616 | 0.460 |
Why?
|
| Interferon-beta | 3 | 2015 | 323 | 0.460 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2012 | 11 | 0.450 |
Why?
|
| Rats | 52 | 2012 | 24260 | 0.450 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 1 | 1 | 2012 | 27 | 0.450 |
Why?
|
| Streptavidin | 1 | 2013 | 81 | 0.440 |
Why?
|
| Chondrosarcoma | 2 | 2014 | 309 | 0.440 |
Why?
|
| Ubiquitins | 1 | 2014 | 384 | 0.440 |
Why?
|
| Genetic Engineering | 12 | 2014 | 951 | 0.440 |
Why?
|
| Immunotherapy, Active | 1 | 2012 | 60 | 0.440 |
Why?
|
| Sarcoma | 3 | 2014 | 1897 | 0.430 |
Why?
|
| Convection | 1 | 2012 | 31 | 0.430 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 494 | 0.430 |
Why?
|
| Anilides | 1 | 2015 | 408 | 0.430 |
Why?
|
| Bacteriophage M13 | 1 | 2012 | 39 | 0.430 |
Why?
|
| Rats, Inbred F344 | 18 | 2011 | 862 | 0.430 |
Why?
|
| Cytomegalovirus | 5 | 2020 | 732 | 0.420 |
Why?
|
| Male | 93 | 2022 | 350118 | 0.420 |
Why?
|
| Female | 99 | 2022 | 380194 | 0.420 |
Why?
|
| Immediate-Early Proteins | 4 | 2014 | 453 | 0.420 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2017 | 3772 | 0.420 |
Why?
|
| Scalp | 1 | 2015 | 380 | 0.420 |
Why?
|
| Megestrol Acetate | 1 | 2011 | 18 | 0.420 |
Why?
|
| Chordoma | 2 | 2014 | 359 | 0.420 |
Why?
|
| Microglia | 4 | 2022 | 1266 | 0.420 |
Why?
|
| Antigens, CD20 | 1 | 2013 | 199 | 0.420 |
Why?
|
| Ferric Compounds | 2 | 2013 | 374 | 0.410 |
Why?
|
| Hemangioblastoma | 1 | 2012 | 70 | 0.410 |
Why?
|
| Glycoproteins | 2 | 2010 | 2263 | 0.410 |
Why?
|
| Skull Base Neoplasms | 2 | 2020 | 284 | 0.410 |
Why?
|
| Gene Amplification | 2 | 2017 | 1063 | 0.400 |
Why?
|
| Azacitidine | 1 | 2013 | 347 | 0.400 |
Why?
|
| Cell Movement | 14 | 2017 | 5217 | 0.400 |
Why?
|
| Acyclovir | 4 | 2016 | 272 | 0.400 |
Why?
|
| Melanoma | 6 | 2023 | 5510 | 0.400 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 8 | 2022 | 11524 | 0.400 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2012 | 152 | 0.390 |
Why?
|
| STAT5 Transcription Factor | 1 | 2012 | 259 | 0.390 |
Why?
|
| Vero Cells | 17 | 2013 | 485 | 0.390 |
Why?
|
| Acetamides | 1 | 2013 | 249 | 0.390 |
Why?
|
| Complement System Proteins | 4 | 2003 | 795 | 0.390 |
Why?
|
| Molecular Biology | 2 | 2014 | 596 | 0.390 |
Why?
|
| Lac Operon | 7 | 2002 | 238 | 0.380 |
Why?
|
| Urinary Catheterization | 1 | 2012 | 202 | 0.380 |
Why?
|
| Antigens, CD | 3 | 2010 | 4026 | 0.380 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2011 | 65 | 0.380 |
Why?
|
| Cytochrome P-450 Enzyme System | 5 | 2004 | 419 | 0.380 |
Why?
|
| Protoporphyrins | 1 | 2011 | 164 | 0.380 |
Why?
|
| Brain Infarction | 1 | 2013 | 299 | 0.380 |
Why?
|
| Dacarbazine | 5 | 2017 | 566 | 0.380 |
Why?
|
| Genes, p16 | 3 | 2008 | 157 | 0.380 |
Why?
|
| Paraganglioma | 1 | 2012 | 143 | 0.370 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2012 | 255 | 0.360 |
Why?
|
| Dexamethasone | 4 | 2022 | 1951 | 0.360 |
Why?
|
| Neoplasm Proteins | 6 | 2019 | 3703 | 0.360 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2015 | 1770 | 0.360 |
Why?
|
| Seizures | 2 | 2013 | 2859 | 0.350 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2013 | 356 | 0.350 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2009 | 50 | 0.350 |
Why?
|
| Biomedical Research | 4 | 2021 | 3309 | 0.350 |
Why?
|
| Rhabdomyosarcoma | 1 | 2012 | 382 | 0.350 |
Why?
|
| Disease Models, Animal | 26 | 2021 | 18029 | 0.340 |
Why?
|
| Complement Inactivator Proteins | 3 | 2004 | 79 | 0.340 |
Why?
|
| Retroviridae | 9 | 2003 | 914 | 0.340 |
Why?
|
| T-Box Domain Proteins | 1 | 2012 | 471 | 0.340 |
Why?
|
| Catheters, Indwelling | 1 | 2012 | 426 | 0.340 |
Why?
|
| Macrocyclic Compounds | 2 | 2020 | 72 | 0.340 |
Why?
|
| Models, Biological | 11 | 2017 | 9583 | 0.340 |
Why?
|
| Diabetic Neuropathies | 1 | 2012 | 400 | 0.340 |
Why?
|
| Promoter Regions, Genetic | 10 | 2018 | 5867 | 0.330 |
Why?
|
| Spinal Nerves | 2 | 2007 | 86 | 0.330 |
Why?
|
| Neoplasm Transplantation | 18 | 2020 | 2085 | 0.330 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 695 | 0.330 |
Why?
|
| Antibodies, Monoclonal | 5 | 2024 | 9274 | 0.330 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2011 | 377 | 0.330 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2013 | 547 | 0.330 |
Why?
|
| Microscopy, Confocal | 3 | 2011 | 1970 | 0.330 |
Why?
|
| Gadolinium DTPA | 1 | 2012 | 836 | 0.330 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 12 | 2020 | 4751 | 0.330 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2010 | 320 | 0.320 |
Why?
|
| Frontal Lobe | 4 | 2012 | 1406 | 0.320 |
Why?
|
| Electromagnetic Fields | 1 | 2010 | 298 | 0.320 |
Why?
|
| Cerebellar Neoplasms | 2 | 2013 | 587 | 0.320 |
Why?
|
| Nanoparticles | 2 | 2019 | 1905 | 0.310 |
Why?
|
| Pituitary Neoplasms | 1 | 2016 | 1345 | 0.310 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 3 | 2001 | 68 | 0.310 |
Why?
|
| Cell Survival | 11 | 2018 | 5882 | 0.310 |
Why?
|
| Visual Pathways | 1 | 2012 | 565 | 0.310 |
Why?
|
| Fibroblasts | 5 | 2015 | 4161 | 0.310 |
Why?
|
| Causalgia | 1 | 2007 | 5 | 0.300 |
Why?
|
| Immunity, Innate | 5 | 2015 | 2958 | 0.300 |
Why?
|
| Valine | 3 | 2016 | 413 | 0.300 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2011 | 604 | 0.300 |
Why?
|
| Herpesvirus 4, Human | 4 | 2012 | 1041 | 0.300 |
Why?
|
| SEER Program | 1 | 2012 | 1508 | 0.300 |
Why?
|
| Xanthines | 2 | 1997 | 121 | 0.290 |
Why?
|
| Rats, Nude | 8 | 2012 | 105 | 0.290 |
Why?
|
| Reoviridae | 2 | 2014 | 161 | 0.290 |
Why?
|
| Antimetabolites, Antineoplastic | 3 | 2009 | 640 | 0.290 |
Why?
|
| Pituitary Diseases | 1 | 2008 | 141 | 0.290 |
Why?
|
| Brain | 21 | 2024 | 26385 | 0.290 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2015 | 2948 | 0.290 |
Why?
|
| Autophagy | 1 | 2014 | 1300 | 0.280 |
Why?
|
| Clinical Trials, Phase III as Topic | 3 | 2024 | 841 | 0.280 |
Why?
|
| Stereotaxic Techniques | 7 | 2012 | 536 | 0.280 |
Why?
|
| T-Lymphocytes | 6 | 2023 | 10180 | 0.280 |
Why?
|
| Cytokines | 4 | 2014 | 7322 | 0.280 |
Why?
|
| Anticonvulsants | 2 | 2013 | 1916 | 0.280 |
Why?
|
| Nervous System Diseases | 3 | 2012 | 1622 | 0.280 |
Why?
|
| Neurosciences | 1 | 2011 | 348 | 0.270 |
Why?
|
| DNA Primers | 4 | 2012 | 2892 | 0.270 |
Why?
|
| Thalamus | 1 | 2012 | 1023 | 0.270 |
Why?
|
| Laser Therapy | 1 | 2013 | 1072 | 0.270 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2015 | 611 | 0.270 |
Why?
|
| Cell Division | 13 | 2006 | 4568 | 0.270 |
Why?
|
| Neoplasms, Second Primary | 1 | 2014 | 1061 | 0.270 |
Why?
|
| Carboxylesterase | 1 | 2005 | 31 | 0.270 |
Why?
|
| Conscious Sedation | 1 | 2010 | 528 | 0.270 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2021 | 3760 | 0.260 |
Why?
|
| Oncogenes | 1 | 2011 | 1265 | 0.260 |
Why?
|
| Cell Cycle | 6 | 2018 | 2967 | 0.260 |
Why?
|
| Urinary Tract Infections | 1 | 2012 | 788 | 0.260 |
Why?
|
| Visual Fields | 1 | 2012 | 1047 | 0.260 |
Why?
|
| RNA, Neoplasm | 3 | 2017 | 769 | 0.260 |
Why?
|
| Signal Transduction | 20 | 2023 | 23403 | 0.260 |
Why?
|
| DNA, Viral | 8 | 2012 | 2225 | 0.260 |
Why?
|
| Interleukin-4 | 4 | 2006 | 1147 | 0.250 |
Why?
|
| Fellowships and Scholarships | 1 | 2013 | 1076 | 0.250 |
Why?
|
| Spinal Cord Diseases | 2 | 2009 | 298 | 0.250 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 422 | 0.250 |
Why?
|
| Neuronavigation | 2 | 2019 | 167 | 0.250 |
Why?
|
| Polyesters | 2 | 2009 | 363 | 0.250 |
Why?
|
| Brain Ischemia | 2 | 2013 | 3265 | 0.250 |
Why?
|
| Antibodies | 1 | 2013 | 2460 | 0.250 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2020 | 1821 | 0.250 |
Why?
|
| Survival Analysis | 8 | 2023 | 10252 | 0.240 |
Why?
|
| Luminescent Measurements | 1 | 2006 | 405 | 0.240 |
Why?
|
| Immunohistochemistry | 17 | 2024 | 11366 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 4479 | 0.240 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2011 | 2038 | 0.240 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2916 | 0.240 |
Why?
|
| STAT1 Transcription Factor | 2 | 2020 | 320 | 0.240 |
Why?
|
| Radiation Injuries | 1 | 2011 | 1180 | 0.240 |
Why?
|
| Immunity | 2 | 2022 | 1012 | 0.240 |
Why?
|
| Immunotoxins | 1 | 2004 | 179 | 0.240 |
Why?
|
| Patient Selection | 2 | 2014 | 4215 | 0.240 |
Why?
|
| Dendritic Cells | 2 | 2012 | 2725 | 0.230 |
Why?
|
| Prognosis | 14 | 2020 | 29063 | 0.230 |
Why?
|
| Radiotherapy | 2 | 2008 | 1533 | 0.230 |
Why?
|
| Cell Line | 16 | 2020 | 15997 | 0.230 |
Why?
|
| RNA, Messenger | 8 | 2015 | 13033 | 0.230 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2017 | 1369 | 0.230 |
Why?
|
| Stem Cells | 4 | 2010 | 3567 | 0.230 |
Why?
|
| Transduction, Genetic | 7 | 2022 | 913 | 0.220 |
Why?
|
| Treatment Outcome | 20 | 2023 | 63114 | 0.220 |
Why?
|
| Snake Venoms | 2 | 2013 | 39 | 0.220 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2011 | 1524 | 0.220 |
Why?
|
| Mutation | 19 | 2022 | 29786 | 0.220 |
Why?
|
| Virus Physiological Phenomena | 1 | 2002 | 18 | 0.220 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2305 | 0.220 |
Why?
|
| DNA, Complementary | 4 | 2014 | 2050 | 0.220 |
Why?
|
| Liver Neoplasms | 6 | 2013 | 4253 | 0.220 |
Why?
|
| Flucytosine | 2 | 2003 | 32 | 0.220 |
Why?
|
| Anesthesia, General | 1 | 2010 | 1171 | 0.220 |
Why?
|
| Cell Proliferation | 15 | 2020 | 10481 | 0.220 |
Why?
|
| Contrast Media | 5 | 2021 | 5300 | 0.210 |
Why?
|
| Antigens, Viral | 2 | 2020 | 1035 | 0.210 |
Why?
|
| Ribonucleotide Reductases | 6 | 2002 | 77 | 0.210 |
Why?
|
| Cross Infection | 1 | 2012 | 1416 | 0.210 |
Why?
|
| Sarcoidosis | 1 | 2008 | 506 | 0.210 |
Why?
|
| Transglutaminases | 6 | 1991 | 194 | 0.210 |
Why?
|
| Electrodes, Implanted | 1 | 2007 | 824 | 0.210 |
Why?
|
| Autoimmune Lymphoproliferative Syndrome | 1 | 2022 | 13 | 0.210 |
Why?
|
| Uterine Neoplasms | 1 | 2011 | 1513 | 0.210 |
Why?
|
| Mice, Inbred NOD | 3 | 2020 | 1878 | 0.210 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2013 | 2214 | 0.210 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2529 | 0.210 |
Why?
|
| Plasmids | 11 | 2012 | 2307 | 0.210 |
Why?
|
| Neovascularization, Physiologic | 2 | 2008 | 1351 | 0.200 |
Why?
|
| Sulfonamides | 2 | 2011 | 1938 | 0.200 |
Why?
|
| Isocitrate Dehydrogenase | 4 | 2020 | 871 | 0.200 |
Why?
|
| Angiogenic Proteins | 2 | 2013 | 104 | 0.200 |
Why?
|
| Health Care Reform | 1 | 2011 | 1261 | 0.200 |
Why?
|
| Cause of Death | 1 | 2012 | 3584 | 0.200 |
Why?
|
| Sciatic Nerve | 3 | 2000 | 607 | 0.200 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 431 | 0.190 |
Why?
|
| 3T3 Cells | 5 | 2015 | 1101 | 0.190 |
Why?
|
| Decanoic Acids | 1 | 2001 | 67 | 0.190 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 82 | 0.190 |
Why?
|
| Interferons | 2 | 2020 | 706 | 0.190 |
Why?
|
| Electric Stimulation Therapy | 1 | 2007 | 605 | 0.190 |
Why?
|
| Bone Marrow Cells | 2 | 2006 | 2513 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 3 | 2016 | 2007 | 0.190 |
Why?
|
| Laminectomy | 2 | 2018 | 234 | 0.190 |
Why?
|
| Dependovirus | 2 | 2022 | 706 | 0.190 |
Why?
|
| Genes, Reporter | 3 | 2020 | 1547 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 6 | 2013 | 2088 | 0.190 |
Why?
|
| Hypersensitivity | 1 | 2009 | 1102 | 0.190 |
Why?
|
| Receptors, LDL | 1 | 2003 | 475 | 0.190 |
Why?
|
| Luciferases | 4 | 2013 | 733 | 0.190 |
Why?
|
| DNA Methylation | 2 | 2018 | 4286 | 0.190 |
Why?
|
| Apoptosis | 14 | 2021 | 9727 | 0.190 |
Why?
|
| Thromboembolism | 1 | 2007 | 986 | 0.190 |
Why?
|
| Gene Expression Profiling | 6 | 2021 | 9438 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2018 | 2849 | 0.180 |
Why?
|
| Patient Care Planning | 1 | 2006 | 921 | 0.180 |
Why?
|
| Up-Regulation | 6 | 2021 | 4217 | 0.180 |
Why?
|
| Genes, Neurofibromatosis 2 | 2 | 2000 | 124 | 0.180 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 3 | 1998 | 257 | 0.180 |
Why?
|
| Pyrazoles | 1 | 2010 | 1972 | 0.180 |
Why?
|
| Blotting, Western | 10 | 2016 | 5179 | 0.180 |
Why?
|
| Gene Order | 2 | 2018 | 176 | 0.180 |
Why?
|
| Lysosomes | 2 | 2015 | 893 | 0.180 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2013 | 442 | 0.180 |
Why?
|
| Antiviral Agents | 8 | 2016 | 2987 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2020 | 5172 | 0.170 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2016 | 1632 | 0.170 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2018 | 2540 | 0.170 |
Why?
|
| Reoperation | 2 | 2007 | 4201 | 0.170 |
Why?
|
| Thoracic Neoplasms | 1 | 2002 | 268 | 0.170 |
Why?
|
| Transplantation, Heterologous | 9 | 2017 | 2382 | 0.170 |
Why?
|
| Adjuvants, Immunologic | 4 | 2022 | 1000 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2018 | 1341 | 0.170 |
Why?
|
| Aged | 24 | 2020 | 163280 | 0.170 |
Why?
|
| Pericytes | 2 | 2019 | 292 | 0.170 |
Why?
|
| Vestibular Diseases | 1 | 2022 | 217 | 0.170 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 3327 | 0.170 |
Why?
|
| Octamer Transcription Factor-1 | 2 | 2015 | 32 | 0.170 |
Why?
|
| beta-Galactosidase | 4 | 2004 | 573 | 0.170 |
Why?
|
| Platinum | 1 | 2020 | 233 | 0.160 |
Why?
|
| Nanostructures | 1 | 2024 | 551 | 0.160 |
Why?
|
| Neurotoxins | 1 | 1999 | 237 | 0.160 |
Why?
|
| Adult | 35 | 2022 | 214055 | 0.160 |
Why?
|
| Nucleoside Deaminases | 1 | 1998 | 58 | 0.160 |
Why?
|
| Biological Transport | 3 | 2020 | 2118 | 0.160 |
Why?
|
| Stathmin | 1 | 2018 | 71 | 0.160 |
Why?
|
| Intensive Care Units | 1 | 2012 | 3679 | 0.160 |
Why?
|
| Heart Diseases | 1 | 2011 | 2788 | 0.160 |
Why?
|
| Osmium | 1 | 2017 | 19 | 0.160 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 3610 | 0.160 |
Why?
|
| Genes, Viral | 1 | 1999 | 718 | 0.160 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2003 | 373 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2020 | 6538 | 0.160 |
Why?
|
| Antigen Presentation | 1 | 2023 | 1284 | 0.160 |
Why?
|
| Middle Aged | 30 | 2020 | 213383 | 0.160 |
Why?
|
| Hospital Mortality | 1 | 2012 | 5317 | 0.150 |
Why?
|
| Hematologic Diseases | 1 | 2022 | 498 | 0.150 |
Why?
|
| Sarcoma, Alveolar Soft Part | 1 | 2017 | 41 | 0.150 |
Why?
|
| Brain Mapping | 2 | 2015 | 6669 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2007 | 1239 | 0.150 |
Why?
|
| Petrous Bone | 3 | 2012 | 86 | 0.150 |
Why?
|
| Syringomyelia | 1 | 2018 | 64 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 780 | 0.150 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 188 | 0.150 |
Why?
|
| Cell-Derived Microparticles | 1 | 2019 | 168 | 0.150 |
Why?
|
| Cytopathogenic Effect, Viral | 6 | 2012 | 156 | 0.150 |
Why?
|
| Macrophages | 4 | 2007 | 5655 | 0.150 |
Why?
|
| Antibodies, Blocking | 1 | 2017 | 253 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 504 | 0.150 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2018 | 168 | 0.150 |
Why?
|
| Gene Expression Regulation | 10 | 2019 | 12072 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2021 | 578 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 11 | 2020 | 21827 | 0.150 |
Why?
|
| Janus Kinase 2 | 1 | 2020 | 528 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2015 | 1990 | 0.150 |
Why?
|
| Injections, Intralesional | 4 | 2004 | 276 | 0.140 |
Why?
|
| Decompression, Surgical | 2 | 2018 | 594 | 0.140 |
Why?
|
| Biotransformation | 3 | 2005 | 168 | 0.140 |
Why?
|
| Vinblastine | 1 | 2018 | 502 | 0.140 |
Why?
|
| Research Support as Topic | 1 | 2021 | 705 | 0.140 |
Why?
|
| Thioguanine | 1 | 1996 | 46 | 0.140 |
Why?
|
| Cognition | 1 | 2014 | 6770 | 0.140 |
Why?
|
| Ischemia | 1 | 2005 | 1907 | 0.140 |
Why?
|
| Escherichia coli | 6 | 2001 | 4217 | 0.140 |
Why?
|
| Drug Delivery Systems | 4 | 2023 | 2219 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 12 | 2017 | 6386 | 0.140 |
Why?
|
| Receptors, Transferrin | 4 | 2004 | 296 | 0.140 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 627 | 0.140 |
Why?
|
| Coordination Complexes | 1 | 2017 | 115 | 0.140 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2018 | 154 | 0.140 |
Why?
|
| Brain Edema | 1 | 2020 | 617 | 0.140 |
Why?
|
| Guidelines as Topic | 2 | 2017 | 1405 | 0.140 |
Why?
|
| Vaccines, Attenuated | 1 | 2017 | 342 | 0.140 |
Why?
|
| Retinal Neoplasms | 1 | 1998 | 144 | 0.140 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2016 | 129 | 0.140 |
Why?
|
| Oligodendroglioma | 2 | 2010 | 279 | 0.140 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 5686 | 0.130 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2016 | 92 | 0.130 |
Why?
|
| Microtubule Proteins | 1 | 2015 | 61 | 0.130 |
Why?
|
| Epitopes | 2 | 2024 | 2571 | 0.130 |
Why?
|
| Neural Tube Defects | 1 | 2018 | 256 | 0.130 |
Why?
|
| Face | 1 | 2022 | 994 | 0.130 |
Why?
|
| Cells, Cultured | 12 | 2020 | 19229 | 0.130 |
Why?
|
| Tyrosine | 1 | 2020 | 1461 | 0.130 |
Why?
|
| NF-kappa B | 2 | 2021 | 2499 | 0.130 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2017 | 279 | 0.130 |
Why?
|
| Genome | 2 | 2003 | 1808 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 783 | 0.130 |
Why?
|
| Immunosuppressive Agents | 5 | 2015 | 4149 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 713 | 0.130 |
Why?
|
| Retinoblastoma | 1 | 1998 | 318 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2010 | 1213 | 0.130 |
Why?
|
| Inflammation | 4 | 2012 | 10638 | 0.130 |
Why?
|
| Neoplasm Seeding | 1 | 2015 | 87 | 0.130 |
Why?
|
| Leupeptins | 1 | 2014 | 122 | 0.130 |
Why?
|
| HEK293 Cells | 4 | 2020 | 4204 | 0.130 |
Why?
|
| Antibodies, Viral | 3 | 2017 | 3176 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2015 | 1142 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2015 | 190 | 0.120 |
Why?
|
| Tight Junctions | 1 | 2017 | 311 | 0.120 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 513 | 0.120 |
Why?
|
| Luminescent Proteins | 5 | 2010 | 853 | 0.120 |
Why?
|
| Phenotype | 7 | 2021 | 16365 | 0.120 |
Why?
|
| Steroid Hydroxylases | 1 | 1994 | 96 | 0.120 |
Why?
|
| Acetyltransferases | 1 | 2015 | 234 | 0.120 |
Why?
|
| Abnormalities, Multiple | 1 | 2022 | 1416 | 0.120 |
Why?
|
| Retinoids | 3 | 1989 | 101 | 0.120 |
Why?
|
| Caspase 3 | 1 | 2016 | 758 | 0.120 |
Why?
|
| Cerebrum | 1 | 2015 | 137 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 5751 | 0.120 |
Why?
|
| Serotonin | 1 | 2018 | 1017 | 0.120 |
Why?
|
| Transcription, Genetic | 6 | 2015 | 7722 | 0.120 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2016 | 433 | 0.120 |
Why?
|
| Fluorescence | 3 | 2011 | 751 | 0.120 |
Why?
|
| Protein Transport | 2 | 2017 | 1988 | 0.110 |
Why?
|
| Flow Cytometry | 6 | 2015 | 5974 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 849 | 0.110 |
Why?
|
| Doxycycline | 1 | 2014 | 326 | 0.110 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2014 | 131 | 0.110 |
Why?
|
| Capsid | 1 | 2015 | 436 | 0.110 |
Why?
|
| Magnetics | 1 | 2016 | 606 | 0.110 |
Why?
|
| Suppression, Genetic | 1 | 2013 | 196 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 15540 | 0.110 |
Why?
|
| Microtubules | 2 | 2016 | 1090 | 0.110 |
Why?
|
| Enzyme Inhibitors | 3 | 2016 | 3798 | 0.110 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 436 | 0.110 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 346 | 0.110 |
Why?
|
| Cell Communication | 1 | 2020 | 1621 | 0.110 |
Why?
|
| Melatonin | 1 | 2018 | 721 | 0.110 |
Why?
|
| Neostriatum | 1 | 1994 | 250 | 0.110 |
Why?
|
| Bradykinin | 5 | 1999 | 214 | 0.110 |
Why?
|
| Acetylation | 1 | 2015 | 1085 | 0.110 |
Why?
|
| Neoplasms, Connective Tissue | 1 | 2012 | 40 | 0.110 |
Why?
|
| RNA, Small Interfering | 4 | 2015 | 3505 | 0.110 |
Why?
|
| Molybdenum | 1 | 2012 | 46 | 0.110 |
Why?
|
| Morpholines | 1 | 2016 | 571 | 0.110 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2020 | 3479 | 0.110 |
Why?
|
| Follow-Up Studies | 12 | 2020 | 39050 | 0.110 |
Why?
|
| Tocotrienols | 1 | 2012 | 3 | 0.110 |
Why?
|
| Neurofibromatosis 2 | 3 | 2005 | 380 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2022 | 2107 | 0.110 |
Why?
|
| Aminopyridines | 1 | 2016 | 542 | 0.100 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2012 | 139 | 0.100 |
Why?
|
| Adenoviruses, Human | 1 | 1994 | 257 | 0.100 |
Why?
|
| Lymphoma | 2 | 2005 | 1877 | 0.100 |
Why?
|
| Neurons | 9 | 2014 | 9338 | 0.100 |
Why?
|
| Forecasting | 4 | 2012 | 2951 | 0.100 |
Why?
|
| Tubulin | 1 | 2015 | 695 | 0.100 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 903 | 0.100 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 941 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2012 | 9734 | 0.100 |
Why?
|
| Neurilemmoma | 4 | 2005 | 547 | 0.100 |
Why?
|
| Peptides, Cyclic | 2 | 2019 | 400 | 0.100 |
Why?
|
| Antigens, Ly | 1 | 2012 | 291 | 0.100 |
Why?
|
| Intermediate Filament Proteins | 3 | 2011 | 269 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 1270 | 0.100 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2011 | 85 | 0.100 |
Why?
|
| Retrospective Studies | 14 | 2022 | 77449 | 0.100 |
Why?
|
| Cytosol | 1 | 2014 | 901 | 0.100 |
Why?
|
| Vesiculovirus | 1 | 2011 | 50 | 0.100 |
Why?
|
| Chondroitin ABC Lyase | 1 | 2010 | 17 | 0.100 |
Why?
|
| Muscle Neoplasms | 1 | 2012 | 139 | 0.100 |
Why?
|
| Mice, Knockout | 6 | 2014 | 14557 | 0.100 |
Why?
|
| Colonic Neoplasms | 5 | 2002 | 2541 | 0.100 |
Why?
|
| RNA Interference | 3 | 2015 | 2889 | 0.100 |
Why?
|
| Free Tissue Flaps | 1 | 2015 | 328 | 0.100 |
Why?
|
| Nerve Growth Factors | 1 | 1994 | 574 | 0.100 |
Why?
|
| Selection Bias | 2 | 2015 | 371 | 0.100 |
Why?
|
| Endocytosis | 1 | 2015 | 985 | 0.100 |
Why?
|
| Time Factors | 15 | 2017 | 40075 | 0.100 |
Why?
|
| Trans-Activators | 2 | 2007 | 2924 | 0.100 |
Why?
|
| Salvage Therapy | 1 | 2017 | 1275 | 0.090 |
Why?
|
| Chelating Agents | 1 | 2012 | 380 | 0.090 |
Why?
|
| Microfluidics | 1 | 2016 | 662 | 0.090 |
Why?
|
| Chondroitin Sulfates | 1 | 2010 | 187 | 0.090 |
Why?
|
| Carcinoma | 5 | 2002 | 2375 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 720 | 0.090 |
Why?
|
| Virus Assembly | 2 | 2003 | 144 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 1855 | 0.090 |
Why?
|
| Radioimmunotherapy | 1 | 2010 | 91 | 0.090 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 2002 | 191 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 430 | 0.090 |
Why?
|
| Ganglia, Spinal | 1 | 2012 | 519 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2009 | 1097 | 0.090 |
Why?
|
| Immunomodulation | 1 | 2014 | 541 | 0.090 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2019 | 625 | 0.090 |
Why?
|
| Liver Diseases | 1 | 2018 | 1253 | 0.090 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 844 | 0.090 |
Why?
|
| Lymphocyte Activation | 2 | 2018 | 5524 | 0.090 |
Why?
|
| Virion | 4 | 2006 | 433 | 0.090 |
Why?
|
| Research Design | 3 | 2021 | 5987 | 0.090 |
Why?
|
| Copper | 1 | 2012 | 366 | 0.090 |
Why?
|
| Interferon Type I | 1 | 2013 | 542 | 0.090 |
Why?
|
| Anesthesia, Inhalation | 1 | 2010 | 223 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2003 | 2775 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2007 | 3462 | 0.090 |
Why?
|
| CpG Islands | 1 | 2013 | 1172 | 0.080 |
Why?
|
| Genome, Viral | 2 | 2003 | 667 | 0.080 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2012 | 523 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2009 | 193 | 0.080 |
Why?
|
| Neck Muscles | 1 | 2009 | 104 | 0.080 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2010 | 323 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2018 | 1580 | 0.080 |
Why?
|
| Drug Approval | 1 | 2015 | 742 | 0.080 |
Why?
|
| Stroke | 1 | 2011 | 9981 | 0.080 |
Why?
|
| Preoperative Period | 1 | 2011 | 549 | 0.080 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2008 | 37 | 0.080 |
Why?
|
| DNA | 7 | 2004 | 7301 | 0.080 |
Why?
|
| Neuroglia | 4 | 2019 | 927 | 0.080 |
Why?
|
| Intraoperative Period | 1 | 2009 | 520 | 0.080 |
Why?
|
| Lithium Chloride | 1 | 2008 | 87 | 0.080 |
Why?
|
| Autoantigens | 1 | 2012 | 892 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 11124 | 0.080 |
Why?
|
| Epidural Space | 1 | 2009 | 124 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 1477 | 0.080 |
Why?
|
| Virus Activation | 2 | 2020 | 319 | 0.080 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2009 | 108 | 0.080 |
Why?
|
| Terpenes | 2 | 1998 | 98 | 0.080 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2010 | 281 | 0.080 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2728 | 0.080 |
Why?
|
| Etoposide | 1 | 2009 | 641 | 0.080 |
Why?
|
| Cervical Atlas | 1 | 2007 | 21 | 0.080 |
Why?
|
| End Stage Liver Disease | 1 | 2012 | 314 | 0.080 |
Why?
|
| Brain Diseases | 2 | 2013 | 1563 | 0.080 |
Why?
|
| Neuroimmunomodulation | 1 | 2009 | 157 | 0.080 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 2007 | 36 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 3846 | 0.080 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 1584 | 0.070 |
Why?
|
| Ependymoma | 1 | 2010 | 334 | 0.070 |
Why?
|
| Glucose | 3 | 2015 | 4397 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 2699 | 0.070 |
Why?
|
| Vincristine | 1 | 2009 | 1039 | 0.070 |
Why?
|
| Radiotherapy, Conformal | 1 | 2010 | 548 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2011 | 3920 | 0.070 |
Why?
|
| RNA, Viral | 1 | 2015 | 2902 | 0.070 |
Why?
|
| Proteomics | 3 | 2018 | 3638 | 0.070 |
Why?
|
| Membrane Proteins | 3 | 2022 | 7880 | 0.070 |
Why?
|
| Receptor, Notch1 | 1 | 2009 | 502 | 0.070 |
Why?
|
| Necrosis | 4 | 2011 | 1643 | 0.070 |
Why?
|
| Adaptive Immunity | 2 | 2022 | 713 | 0.070 |
Why?
|
| Brain Injuries | 1 | 2018 | 2025 | 0.070 |
Why?
|
| Nervous System Neoplasms | 1 | 2006 | 91 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2015 | 2969 | 0.070 |
Why?
|
| Medical Oncology | 3 | 2021 | 2265 | 0.070 |
Why?
|
| Mitotic Index | 1 | 2006 | 172 | 0.070 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1941 | 0.070 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 1116 | 0.070 |
Why?
|
| Vertebroplasty | 1 | 2007 | 77 | 0.070 |
Why?
|
| Arm | 1 | 2009 | 589 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 693 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2005 | 34 | 0.070 |
Why?
|
| Fatal Outcome | 2 | 2002 | 1850 | 0.070 |
Why?
|
| Alcoholism | 1 | 2016 | 1906 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 1222 | 0.070 |
Why?
|
| Age Factors | 4 | 2015 | 18370 | 0.070 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2009 | 259 | 0.070 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 1392 | 0.070 |
Why?
|
| Career Choice | 1 | 2012 | 744 | 0.070 |
Why?
|
| Protons | 2 | 2021 | 1127 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 1995 | 1580 | 0.070 |
Why?
|
| Vaccines | 1 | 2014 | 822 | 0.070 |
Why?
|
| Bone Cements | 1 | 2007 | 325 | 0.070 |
Why?
|
| Optics and Photonics | 1 | 2007 | 321 | 0.070 |
Why?
|
| Blood Volume | 2 | 2004 | 565 | 0.070 |
Why?
|
| Tretinoin | 1 | 1988 | 517 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2012 | 1359 | 0.070 |
Why?
|
| Models, Animal | 4 | 2006 | 2171 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 4560 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 19905 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1677 | 0.060 |
Why?
|
| Adenovirus E1B Proteins | 1 | 2004 | 15 | 0.060 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2006 | 294 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2020 | 10943 | 0.060 |
Why?
|
| Dogs | 4 | 2012 | 3912 | 0.060 |
Why?
|
| RNA-Binding Proteins | 3 | 2020 | 1903 | 0.060 |
Why?
|
| Cricetinae | 2 | 2012 | 2472 | 0.060 |
Why?
|
| Meninges | 1 | 2006 | 190 | 0.060 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 950 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1038 | 0.060 |
Why?
|
| NIH 3T3 Cells | 2 | 2019 | 677 | 0.060 |
Why?
|
| Proteome | 1 | 2014 | 1799 | 0.060 |
Why?
|
| Risk Factors | 6 | 2015 | 72290 | 0.060 |
Why?
|
| Phagocytes | 1 | 2006 | 297 | 0.060 |
Why?
|
| Gene Deletion | 5 | 2010 | 2751 | 0.060 |
Why?
|
| Prednisone | 1 | 2009 | 1574 | 0.060 |
Why?
|
| Radiation Dosage | 2 | 2011 | 1928 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2007 | 578 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2010 | 1681 | 0.060 |
Why?
|
| Cosmids | 2 | 2001 | 107 | 0.060 |
Why?
|
| Recombination, Genetic | 3 | 2012 | 1586 | 0.060 |
Why?
|
| Chemokine CXCL12 | 1 | 2006 | 464 | 0.060 |
Why?
|
| Angiography | 2 | 2009 | 1639 | 0.060 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2004 | 31 | 0.060 |
Why?
|
| Ki-67 Antigen | 1 | 2006 | 644 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5442 | 0.060 |
Why?
|
| Base Sequence | 6 | 2020 | 12797 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2899 | 0.060 |
Why?
|
| Young Adult | 8 | 2018 | 56430 | 0.060 |
Why?
|
| Radiography | 2 | 2012 | 7023 | 0.060 |
Why?
|
| Neuroma, Acoustic | 4 | 2005 | 451 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6365 | 0.060 |
Why?
|
| Mammalian orthoreovirus 3 | 1 | 2003 | 44 | 0.060 |
Why?
|
| Phosphorylation | 4 | 2018 | 8436 | 0.060 |
Why?
|
| Diagnostic Imaging | 2 | 2011 | 3507 | 0.060 |
Why?
|
| Homeostasis | 1 | 2014 | 3340 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2010 | 1486 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1504 | 0.060 |
Why?
|
| Cell Differentiation | 4 | 2009 | 11483 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2007 | 9648 | 0.060 |
Why?
|
| Callithrix | 1 | 2003 | 93 | 0.060 |
Why?
|
| Sterols | 1 | 2003 | 63 | 0.060 |
Why?
|
| Receptors, Virus | 2 | 2020 | 648 | 0.060 |
Why?
|
| Tumor Stem Cell Assay | 2 | 2009 | 118 | 0.060 |
Why?
|
| Histocytochemistry | 2 | 1994 | 719 | 0.060 |
Why?
|
| Homozygote | 1 | 2008 | 1785 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 2942 | 0.060 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 182 | 0.060 |
Why?
|
| Cell Death | 3 | 2002 | 1706 | 0.060 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2003 | 60 | 0.060 |
Why?
|
| Transformation, Genetic | 1 | 2003 | 192 | 0.060 |
Why?
|
| Random Allocation | 2 | 2023 | 2429 | 0.060 |
Why?
|
| Recombinant Proteins | 5 | 2008 | 6622 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2009 | 1861 | 0.050 |
Why?
|
| Blotting, Southern | 2 | 2001 | 803 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2009 | 2234 | 0.050 |
Why?
|
| Endothelial Cells | 3 | 2017 | 3479 | 0.050 |
Why?
|
| Cytosine Deaminase | 2 | 2004 | 68 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 244 | 0.050 |
Why?
|
| Sleep | 1 | 2018 | 4623 | 0.050 |
Why?
|
| Methotrexate | 1 | 2009 | 1727 | 0.050 |
Why?
|
| Endoscopy | 1 | 2012 | 1785 | 0.050 |
Why?
|
| Herpesviridae | 1 | 2003 | 109 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 5708 | 0.050 |
Why?
|
| Kynurenine | 1 | 2023 | 139 | 0.050 |
Why?
|
| Indoles | 3 | 2015 | 1839 | 0.050 |
Why?
|
| Genetic Complementation Test | 1 | 2003 | 562 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1403 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2024 | 353 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2008 | 1200 | 0.050 |
Why?
|
| Chemokine CCL5 | 1 | 2022 | 209 | 0.050 |
Why?
|
| Camptothecin | 1 | 2005 | 576 | 0.050 |
Why?
|
| HeLa Cells | 3 | 2017 | 3128 | 0.050 |
Why?
|
| Cerebellum | 1 | 2009 | 1488 | 0.050 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2005 | 664 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2007 | 1539 | 0.050 |
Why?
|
| Neoplasm Metastasis | 2 | 2011 | 4851 | 0.050 |
Why?
|
| Ohio | 1 | 2022 | 337 | 0.050 |
Why?
|
| Arabinofuranosyluracil | 1 | 2001 | 10 | 0.050 |
Why?
|
| Survival Rate | 4 | 2005 | 12788 | 0.050 |
Why?
|
| HT29 Cells | 3 | 2012 | 200 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2006 | 1097 | 0.050 |
Why?
|
| Oxides | 3 | 2002 | 405 | 0.050 |
Why?
|
| Neurofibromin 2 | 2 | 2000 | 267 | 0.050 |
Why?
|
| Oximes | 1 | 2023 | 311 | 0.050 |
Why?
|
| Cell Adhesion | 3 | 2016 | 3144 | 0.050 |
Why?
|
| Consensus | 2 | 2021 | 2959 | 0.050 |
Why?
|
| Carcinogens | 1 | 2004 | 466 | 0.050 |
Why?
|
| Phosphoramide Mustards | 1 | 2001 | 16 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 4 | 2011 | 4462 | 0.050 |
Why?
|
| Interleukins | 1 | 2006 | 791 | 0.050 |
Why?
|
| Macaca | 1 | 2022 | 440 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2017 | 1341 | 0.050 |
Why?
|
| Rodentia | 1 | 2022 | 261 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2006 | 2716 | 0.050 |
Why?
|
| Tryptophan | 1 | 2023 | 478 | 0.050 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 20822 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2009 | 1809 | 0.050 |
Why?
|
| Models, Structural | 1 | 2001 | 361 | 0.050 |
Why?
|
| Cervical Vertebrae | 1 | 2007 | 975 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2007 | 2618 | 0.050 |
Why?
|
| Aged, 80 and over | 8 | 2017 | 57776 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2003 | 2255 | 0.050 |
Why?
|
| Stem Cell Transplantation | 2 | 2007 | 1620 | 0.050 |
Why?
|
| Elapid Venoms | 1 | 2000 | 40 | 0.050 |
Why?
|
| Spinal Fractures | 1 | 2007 | 696 | 0.050 |
Why?
|
| Societies | 1 | 2021 | 104 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2008 | 3002 | 0.050 |
Why?
|
| Radial Nerve | 1 | 2000 | 43 | 0.050 |
Why?
|
| Nanofibers | 2 | 2011 | 66 | 0.050 |
Why?
|
| Tyrosine Transaminase | 1 | 2020 | 11 | 0.050 |
Why?
|
| Dominance, Cerebral | 3 | 2004 | 635 | 0.050 |
Why?
|
| Arteries | 1 | 2005 | 1119 | 0.050 |
Why?
|
| Injections, Intraventricular | 3 | 2014 | 230 | 0.050 |
Why?
|
| CHO Cells | 1 | 2003 | 1406 | 0.050 |
Why?
|
| Cell Growth Processes | 2 | 2015 | 399 | 0.050 |
Why?
|
| Length of Stay | 2 | 2011 | 6309 | 0.050 |
Why?
|
| Adaptation, Biological | 1 | 2001 | 153 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5221 | 0.050 |
Why?
|
| Disease Progression | 6 | 2017 | 13284 | 0.040 |
Why?
|
| Adolescent | 9 | 2022 | 85781 | 0.040 |
Why?
|
| Complement Activation | 1 | 2002 | 453 | 0.040 |
Why?
|
| Primates | 1 | 2022 | 545 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 1 | 2011 | 2647 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2012 | 2291 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2005 | 1125 | 0.040 |
Why?
|
| Injections | 2 | 2000 | 840 | 0.040 |
Why?
|
| Propensity Score | 2 | 2017 | 1781 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2009 | 1880 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 2503 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2022 | 326 | 0.040 |
Why?
|
| Receptors, Melatonin | 1 | 2018 | 31 | 0.040 |
Why?
|
| Endothelium, Vascular | 3 | 2005 | 4456 | 0.040 |
Why?
|
| Risk | 1 | 2011 | 9687 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2004 | 636 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2003 | 1150 | 0.040 |
Why?
|
| COS Cells | 2 | 2011 | 1161 | 0.040 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2018 | 30 | 0.040 |
Why?
|
| Laughter | 1 | 1998 | 19 | 0.040 |
Why?
|
| Nitrogen | 1 | 2020 | 344 | 0.040 |
Why?
|
| Anthracenes | 1 | 1998 | 84 | 0.040 |
Why?
|
| Drug Resistance | 2 | 1994 | 1609 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 1375 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2019 | 2250 | 0.040 |
Why?
|
| Galactosides | 1 | 1998 | 52 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2006 | 2187 | 0.040 |
Why?
|
| Antimetabolites | 1 | 1998 | 125 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2020 | 13815 | 0.040 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2018 | 77 | 0.040 |
Why?
|
| Single-Chain Antibodies | 1 | 2018 | 108 | 0.040 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 206 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2019 | 1442 | 0.040 |
Why?
|
| Anesthesia | 1 | 2009 | 1561 | 0.040 |
Why?
|
| Culture Media, Conditioned | 2 | 1998 | 537 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2008 | 3200 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2022 | 810 | 0.040 |
Why?
|
| Ifosfamide | 1 | 1998 | 228 | 0.040 |
Why?
|
| Receptor Aggregation | 1 | 2017 | 80 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 3617 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2002 | 2008 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2020 | 802 | 0.040 |
Why?
|
| Gamma Rays | 1 | 2019 | 320 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 588 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 1 | 1998 | 282 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 890 | 0.040 |
Why?
|
| Genome, Human | 2 | 2020 | 4420 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1723 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2019 | 256 | 0.040 |
Why?
|
| Species Specificity | 1 | 2002 | 2478 | 0.040 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2017 | 44 | 0.040 |
Why?
|
| Critical Care | 1 | 2010 | 2647 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2008 | 3023 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2017 | 6171 | 0.040 |
Why?
|
| Thoracic Vertebrae | 1 | 2002 | 608 | 0.040 |
Why?
|
| Antibody Formation | 2 | 1999 | 1402 | 0.040 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2003 | 570 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2020 | 426 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2012 | 8949 | 0.040 |
Why?
|
| DNA Repair Enzymes | 1 | 2018 | 349 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 956 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 2649 | 0.040 |
Why?
|
| DNA, Neoplasm | 3 | 1998 | 1758 | 0.040 |
Why?
|
| Spinal Cord Compression | 2 | 2009 | 235 | 0.030 |
Why?
|
| Cisterna Magna | 1 | 1996 | 41 | 0.030 |
Why?
|
| Receptors, Antigen | 1 | 2016 | 53 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 14722 | 0.030 |
Why?
|
| Comorbidity | 1 | 2011 | 10388 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1999 | 755 | 0.030 |
Why?
|
| Neurofibromatosis 1 | 2 | 1992 | 569 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2001 | 693 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2019 | 321 | 0.030 |
Why?
|
| Mentors | 1 | 2021 | 631 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 4554 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2019 | 304 | 0.030 |
Why?
|
| Osmosis | 1 | 1995 | 113 | 0.030 |
Why?
|
| Fluphenazine | 1 | 2015 | 36 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2020 | 1266 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2020 | 1460 | 0.030 |
Why?
|
| Subrenal Capsule Assay | 2 | 1992 | 26 | 0.030 |
Why?
|
| Parietal Bone | 1 | 2015 | 47 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12261 | 0.030 |
Why?
|
| Lymphokines | 1 | 2019 | 949 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 557 | 0.030 |
Why?
|
| Models, Genetic | 2 | 2001 | 3494 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2003 | 1357 | 0.030 |
Why?
|
| Moloney murine leukemia virus | 1 | 1995 | 139 | 0.030 |
Why?
|
| Frontal Sinus | 1 | 2015 | 50 | 0.030 |
Why?
|
| Hospitalization | 1 | 2015 | 10262 | 0.030 |
Why?
|
| Virulence | 1 | 1999 | 1333 | 0.030 |
Why?
|
| Frontal Bone | 1 | 2015 | 105 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2309 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2019 | 40561 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 3508 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 13989 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 1681 | 0.030 |
Why?
|
| Vimentin | 1 | 2016 | 261 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 738 | 0.030 |
Why?
|
| Microscopy | 2 | 2012 | 903 | 0.030 |
Why?
|
| Iron | 3 | 2002 | 1774 | 0.030 |
Why?
|
| Cerebral Aqueduct | 1 | 1994 | 39 | 0.030 |
Why?
|
| Academies and Institutes | 1 | 2017 | 317 | 0.030 |
Why?
|
| Diagnosis, Differential | 4 | 2005 | 12959 | 0.030 |
Why?
|
| Injections, Intra-Arterial | 3 | 1999 | 193 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 1999 | 518 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 1537 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2015 | 408 | 0.030 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2015 | 295 | 0.030 |
Why?
|
| Acetylcholinesterase | 1 | 1994 | 153 | 0.030 |
Why?
|
| Pregnancy | 2 | 2013 | 29144 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2017 | 582 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 5853 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 2 | 2010 | 1081 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2016 | 675 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2015 | 496 | 0.030 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2015 | 234 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 2012 | 2327 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2017 | 1950 | 0.030 |
Why?
|
| Microspheres | 1 | 2016 | 777 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15076 | 0.030 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2018 | 428 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 2839 | 0.030 |
Why?
|
| Fluorouracil | 1 | 1998 | 1619 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 3647 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2020 | 3588 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2007 | 20129 | 0.030 |
Why?
|
| Kinetics | 1 | 2001 | 6473 | 0.030 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2000 | 1381 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2004 | 2921 | 0.030 |
Why?
|
| Annexin A2 | 1 | 2012 | 44 | 0.030 |
Why?
|
| Mitosis | 1 | 1998 | 1208 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 1838 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-2 | 2 | 2005 | 190 | 0.030 |
Why?
|
| Sirolimus | 1 | 2020 | 1564 | 0.030 |
Why?
|
| Plasmacytoma | 1 | 1993 | 183 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 733 | 0.030 |
Why?
|
| Ligands | 2 | 2016 | 3282 | 0.030 |
Why?
|
| Clinical Protocols | 2 | 2009 | 1462 | 0.030 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2011 | 16 | 0.030 |
Why?
|
| Tocopherols | 1 | 2012 | 43 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2001 | 1736 | 0.030 |
Why?
|
| Neurofibroma | 1 | 1992 | 106 | 0.030 |
Why?
|
| Cell Migration Assays | 1 | 2011 | 23 | 0.030 |
Why?
|
| United States | 2 | 2021 | 69872 | 0.030 |
Why?
|
| Cyclic S-Oxides | 1 | 2011 | 21 | 0.030 |
Why?
|
| Decision Making | 1 | 2006 | 3887 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1995 | 981 | 0.030 |
Why?
|
| Anthraquinones | 1 | 2011 | 37 | 0.030 |
Why?
|
| Endoscopes | 1 | 2012 | 175 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 1915 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2019 | 2715 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 2012 | 349 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2012 | 5788 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 2759 | 0.030 |
Why?
|
| Myosin Type II | 1 | 2011 | 68 | 0.030 |
Why?
|
| Genes, erbB-1 | 2 | 2002 | 161 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2011 | 23338 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3768 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 4420 | 0.030 |
Why?
|
| Enzyme Induction | 2 | 1989 | 475 | 0.020 |
Why?
|
| Cisplatin | 1 | 2017 | 1662 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2866 | 0.020 |
Why?
|
| Polystyrenes | 1 | 2011 | 112 | 0.020 |
Why?
|
| Metabolomics | 1 | 2020 | 1484 | 0.020 |
Why?
|
| Cloning, Molecular | 3 | 1998 | 4320 | 0.020 |
Why?
|
| Microcirculation | 2 | 2007 | 1286 | 0.020 |
Why?
|
| Tomography | 1 | 2012 | 390 | 0.020 |
Why?
|
| Eosinophilia | 1 | 1995 | 541 | 0.020 |
Why?
|
| Methylation | 1 | 2013 | 1106 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
| Bile Duct Neoplasms | 1 | 2015 | 567 | 0.020 |
Why?
|
| Cholangiocarcinoma | 1 | 2015 | 516 | 0.020 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1990 | 159 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 944 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 1801 | 0.020 |
Why?
|
| Computers | 1 | 2012 | 612 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2022 | 53288 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 3597 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2022 | 41006 | 0.020 |
Why?
|
| Venous Pressure | 1 | 2009 | 56 | 0.020 |
Why?
|
| Arrestins | 1 | 2009 | 74 | 0.020 |
Why?
|
| Regeneration | 1 | 2018 | 1485 | 0.020 |
Why?
|
| Astrocytes | 1 | 2017 | 1270 | 0.020 |
Why?
|
| Neuroendocrine Tumors | 1 | 2015 | 594 | 0.020 |
Why?
|
| Equipment Design | 1 | 2018 | 3582 | 0.020 |
Why?
|
| Hybridomas | 1 | 1990 | 452 | 0.020 |
Why?
|
| Retinol-Binding Proteins | 1 | 1989 | 65 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12245 | 0.020 |
Why?
|
| Densitometry | 1 | 1989 | 156 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1655 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 520 | 0.020 |
Why?
|
| Molecular Probes | 2 | 2002 | 316 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 4803 | 0.020 |
Why?
|
| Cadaver | 1 | 2012 | 1337 | 0.020 |
Why?
|
| Microfilament Proteins | 2 | 2007 | 1152 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 17446 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 323 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2009 | 137 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 1678 | 0.020 |
Why?
|
| Butyrates | 1 | 2008 | 163 | 0.020 |
Why?
|
| DNA Fragmentation | 2 | 1998 | 242 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2010 | 835 | 0.020 |
Why?
|
| Biopsy | 3 | 2007 | 6756 | 0.020 |
Why?
|
| Vitamin E | 1 | 2012 | 869 | 0.020 |
Why?
|
| Polyamines | 1 | 1988 | 120 | 0.020 |
Why?
|
| Brain Stem | 1 | 2012 | 846 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2018 | 3086 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1999 | 2531 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 18111 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2016 | 2504 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1989 | 1581 | 0.020 |
Why?
|
| Child | 5 | 2022 | 77709 | 0.020 |
Why?
|
| Liver | 4 | 2007 | 7474 | 0.020 |
Why?
|
| Phosphonoacetic Acid | 1 | 2006 | 55 | 0.020 |
Why?
|
| Infant | 2 | 2022 | 35136 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 2008 | 277 | 0.020 |
Why?
|
| Photons | 1 | 2010 | 588 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 1602 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2007 | 224 | 0.020 |
Why?
|
| Chemokine CCL21 | 1 | 2006 | 51 | 0.020 |
Why?
|
| Clone Cells | 2 | 2001 | 1692 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1157 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2009 | 607 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2011 | 1355 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7729 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 3521 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 813 | 0.020 |
Why?
|
| Neck Pain | 1 | 2007 | 180 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2007 | 215 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2009 | 893 | 0.020 |
Why?
|
| Quadriplegia | 1 | 2007 | 223 | 0.020 |
Why?
|
| Injections, Spinal | 2 | 1996 | 303 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 2 | 1998 | 360 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 4042 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2009 | 1472 | 0.020 |
Why?
|
| Radiculopathy | 1 | 2007 | 197 | 0.020 |
Why?
|
| Chemokines, CC | 1 | 2006 | 291 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 9386 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 1157 | 0.020 |
Why?
|
| Genotype | 2 | 2015 | 12951 | 0.020 |
Why?
|
| Feasibility Studies | 3 | 2000 | 5078 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6895 | 0.020 |
Why?
|
| Monophenol Monooxygenase | 1 | 2004 | 69 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2011 | 956 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2009 | 783 | 0.020 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2004 | 29 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2006 | 526 | 0.020 |
Why?
|
| Albumins | 1 | 2007 | 569 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1998 | 878 | 0.010 |
Why?
|
| Electromyography | 1 | 2009 | 1379 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2008 | 1792 | 0.010 |
Why?
|
| Adenovirus E1 Proteins | 1 | 2003 | 6 | 0.010 |
Why?
|
| Genetic Markers | 2 | 2002 | 2634 | 0.010 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2010 | 806 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2007 | 798 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2010 | 2879 | 0.010 |
Why?
|
| Hand | 1 | 2009 | 884 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3701 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2121 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5535 | 0.010 |
Why?
|
| Mucins | 1 | 2007 | 564 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9959 | 0.010 |
Why?
|
| Gyrus Cinguli | 1 | 1990 | 1091 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 472 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 2505 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 1312 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1856 | 0.010 |
Why?
|
| Heparin | 1 | 1990 | 1637 | 0.010 |
Why?
|
| Safety | 1 | 2008 | 1186 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2010 | 1640 | 0.010 |
Why?
|
| Algorithms | 4 | 2007 | 13881 | 0.010 |
Why?
|
| Purines | 1 | 2006 | 594 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 12354 | 0.010 |
Why?
|
| alpha-Synuclein | 1 | 2009 | 723 | 0.010 |
Why?
|
| Atrophy | 1 | 2007 | 1583 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1990 | 1826 | 0.010 |
Why?
|
| Rare Diseases | 1 | 2007 | 553 | 0.010 |
Why?
|
| Chromosomes, Artificial, P1 Bacteriophage | 1 | 2001 | 3 | 0.010 |
Why?
|
| Mucin-1 | 1 | 2007 | 543 | 0.010 |
Why?
|
| Cell Separation | 1 | 2008 | 1751 | 0.010 |
Why?
|
| Diuretics, Osmotic | 1 | 2002 | 37 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 2 | 2015 | 5256 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2008 | 1221 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2004 | 422 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2004 | 475 | 0.010 |
Why?
|
| Telomerase | 1 | 2007 | 730 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2002 | 234 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 2008 | 6489 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2005 | 1682 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 1086 | 0.010 |
Why?
|
| Mannitol | 1 | 2002 | 181 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
| Choline | 1 | 2002 | 493 | 0.010 |
Why?
|
| Colorectal Neoplasms | 2 | 1999 | 6773 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2000 | 96 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2012 | 2119 | 0.010 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1990 | 1444 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2013 | 5097 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3870 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2002 | 337 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 1525 | 0.010 |
Why?
|
| Autoradiography | 1 | 2001 | 745 | 0.010 |
Why?
|
| Echo-Planar Imaging | 1 | 2004 | 659 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 2000 | 258 | 0.010 |
Why?
|
| Schwann Cells | 1 | 2000 | 195 | 0.010 |
Why?
|
| Leukocytes | 1 | 2007 | 2043 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2000 | 268 | 0.010 |
Why?
|
| Chromogenic Compounds | 1 | 1999 | 30 | 0.010 |
Why?
|
| Brain Abscess | 1 | 2000 | 118 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2000 | 351 | 0.010 |
Why?
|
| tau Proteins | 1 | 2009 | 1868 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 1423 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 1799 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2012 | 3297 | 0.010 |
Why?
|
| Insect Proteins | 1 | 2000 | 258 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 5391 | 0.010 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 1028 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 2557 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1999 | 898 | 0.010 |
Why?
|
| Hamartoma | 1 | 2000 | 238 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 8301 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 203 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2004 | 2971 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2001 | 1144 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 1454 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 8663 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1998 | 216 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2001 | 1032 | 0.010 |
Why?
|
| Mosaicism | 1 | 2000 | 441 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 2373 | 0.010 |
Why?
|
| Genomics | 2 | 2004 | 5720 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2007 | 2494 | 0.010 |
Why?
|
| Incidence | 1 | 2015 | 20947 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 1866 | 0.010 |
Why?
|
| Occipital Bone | 1 | 1996 | 54 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2000 | 880 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 2716 | 0.010 |
Why?
|
| Cerebellopontine Angle | 1 | 1996 | 55 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1782 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 1996 | 79 | 0.010 |
Why?
|
| ROC Curve | 1 | 2004 | 3527 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 1996 | 90 | 0.010 |
Why?
|
| Glutathione | 1 | 1998 | 589 | 0.010 |
Why?
|
| Chromatin | 1 | 2007 | 2934 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 1730 | 0.010 |
Why?
|
| Liposomes | 1 | 1999 | 759 | 0.010 |
Why?
|
| Goals | 1 | 2000 | 706 | 0.010 |
Why?
|
| Remission Induction | 1 | 2000 | 2386 | 0.010 |
Why?
|
| Cats | 1 | 1995 | 998 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 2000 | 683 | 0.010 |
Why?
|
| Cataract | 1 | 2000 | 834 | 0.010 |
Why?
|
| Immunization | 1 | 1998 | 1256 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 3271 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 12208 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 2000 | 760 | 0.010 |
Why?
|
| Thiazoles | 1 | 2000 | 1483 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2007 | 5102 | 0.010 |
Why?
|
| Health Status | 1 | 2005 | 4034 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2000 | 2617 | 0.010 |
Why?
|
| Carrier Proteins | 2 | 2000 | 5021 | 0.010 |
Why?
|
| Temporal Bone | 1 | 1996 | 661 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1993 | 666 | 0.010 |
Why?
|
| Rabbits | 1 | 1998 | 4894 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2000 | 4186 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 1995 | 952 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2000 | 1708 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 11031 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1991 | 263 | 0.010 |
Why?
|
| Spleen | 1 | 1996 | 2362 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1085 | 0.010 |
Why?
|
| DNA Damage | 1 | 1998 | 2432 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2000 | 2020 | 0.000 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1988 | 232 | 0.000 |
Why?
|
| Kidney | 1 | 2003 | 7186 | 0.000 |
Why?
|
| Vaccination | 1 | 2000 | 3278 | 0.000 |
Why?
|
| Hippocampus | 1 | 1998 | 3675 | 0.000 |
Why?
|
| Epidermis | 1 | 1988 | 528 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1991 | 2126 | 0.000 |
Why?
|
| Binding Sites | 1 | 1991 | 6114 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1991 | 2455 | 0.000 |
Why?
|
| Monocytes | 1 | 1988 | 2596 | 0.000 |
Why?
|
| Proteins | 1 | 1988 | 6103 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1988 | 3523 | 0.000 |
Why?
|